Farmacéutica
409 empresas de esta industria que cotizan en EE. UU.
Empresas
409 listadas
| Empresa | Ingresos | Utilidad neta | Margen | ROE | Ingresos 5a | Años |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | $94.19 bi | $26.80 bi | 28.5% | — | +2.7% | 19 |
| LLYELI LILLY & Co | $65.18 bi | $20.64 bi | 31.7% | 101.2% | +21.6% | 19 |
| MRKMerck & Co., Inc. | $65.01 bi | $18.25 bi | 28.1% | 36.9% | +9.4% | 19 |
| PFEPfizer Inc. | $62.58 bi | $7.77 bi | 12.4% | 8.9% | +8.5% | 19 |
| ABBVAbbVie Inc. | $61.16 bi | $4.23 bi | 6.9% | 15367.3% | +6.0% | 15 |
| AZNASTRAZENECA PLC | $58.74 bi | $10.22 bi | 17.4% | 22.9% | +17.2% | 11 |
| NVSNovartis AG | $54.53 bi | $13.98 bi | 25.6% | 31.0% | +2.3% | 10 |
| BMYBristol-Myers Squibb Company | $48.19 bi | $7.05 bi | 14.6% | 40.5% | +2.5% | 19 |
| ABTABBOTT LABORATORIES | $44.33 bi | $6.52 bi | 14.7% | 13.1% | +5.1% | 19 |
| TEVATEVA PHARMACEUTICAL INDUSTRIES LIMITED | $17.26 bi | $1.41 bi | 8.2% | 21.2% | +0.7% | 17 |
| REGNREGENERON PHARMACEUTICALS, INC. | $14.34 bi | $4.50 bi | 31.4% | 14.9% | +11.0% | 18 |
| VTRSViatris Inc | $14.25 bi | -$3.51 bi | -24.7% | — | +3.6% | 8 |
| VRTXVERTEX PHARMACEUTICALS INC / MA | $12.00 bi | $3.95 bi | 32.9% | 22.5% | +14.1% | 18 |
| BHCBausch Health Companies Inc. | $10.27 bi | $157.0 mi | 1.5% | — | +5.0% | 18 |
| ZTSZoetis Inc. | $9.47 bi | $2.67 bi | 28.2% | 66.0% | +7.2% | 15 |
| OGNOrganon & Co. | $6.22 bi | $187.0 mi | 3.0% | 30.6% | -1.0% | 7 |
| ONCBEONE MEDICINES LTD. | $5.34 bi | $286.9 mi | 5.4% | 7.5% | +76.8% | 12 |
| ELANElanco Animal Health Incorporated | $4.71 bi | -$232.0 mi | -4.9% | -3.7% | +7.6% | 10 |
| JAZZJazz Pharmaceuticals plc | $4.27 bi | -$356.1 mi | -8.3% | -8.5% | +12.5% | 17 |
| PRGOPerrigo Company plc | $4.25 bi | -$1.43 bi | -33.5% | -39.3% | +0.8% | 14 |
| ALNYALNYLAM PHARMACEUTICALS, INC. | $3.71 bi | $313.7 mi | 8.4% | 73.3% | +49.8% | 13 |
| BMRNBioMarin Pharmaceutical Inc | $3.22 bi | $348.9 mi | 10.8% | 5.9% | +11.6% | 18 |
| UTHRUNITED THERAPEUTICS Corp | $3.18 bi | $1.33 bi | 41.9% | 19.7% | +16.5% | 18 |
| AMRXAMNEAL PHARMACEUTICALS, INC. | $3.02 bi | $72.1 mi | 2.4% | — | +8.7% | 10 |
| RPRXRoyalty Pharma plc | $2.38 bi | $770.9 mi | 32.4% | — | +2.3% | 8 |
| SRPTSarepta Therapeutics, Inc. | $1.86 bi | -$713.4 mi | -38.3% | -53.5% | +32.5% | 12 |
| PTCTPTC Therapeutics, Inc. | $1.73 bi | $682.6 mi | 39.4% | — | +35.4% | 15 |
| ALKSAlkermes plc. | $1.48 bi | $241.7 mi | 16.4% | 14.7% | +7.3% | 17 |
| INDVIndivior Pharmaceuticals, Inc. | $1.24 bi | $210.0 mi | 16.9% | — | — | 4 |
| PBHPrestige Consumer Healthcare Inc. | $1.09 bi | $190.3 mi | 17.5% | 10.2% | +2.9% | 17 |
| ACADACADIA PHARMACEUTICALS INC | $1.07 bi | $391.0 mi | 36.5% | 39.9% | +19.4% | 17 |
| LEGNLegend Biotech Corp | $1.03 bi | -$296.8 mi | -28.8% | -28.5% | +68.8% | 8 |
| MDGLMADRIGAL PHARMACEUTICALS, INC. | $958.4 mi | -$288.3 mi | -30.1% | -42.5% | — | 10 |
| IONSIONIS PHARMACEUTICALS, INC. | $943.7 mi | -$381.4 mi | -40.4% | -70.8% | +5.3% | 18 |
| ANIPANI Pharmaceuticals, Inc. | $883.4 mi | $78.3 mi | 8.9% | 16.6% | +33.5% | 17 |
| HRMYHARMONY BIOSCIENCES HOLDINGS, INC. | $868.5 mi | $158.7 mi | 18.3% | 20.8% | +40.3% | 7 |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | $829.4 mi | -$1.6 mi | -0.2% | -0.5% | +56.6% | 15 |
| TLXTelix Pharmaceuticals Limited | $803.8 mi | -$7.1 mi | -0.9% | — | — | 4 |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | $780.6 mi | $62.9 mi | 8.1% | 23.7% | +20.3% | 10 |
| CORTCORCEPT THERAPEUTICS INC | $761.4 mi | $99.7 mi | 13.1% | 15.0% | +16.6% | 15 |
| PCRXPACIRA BIOSCIENCES, INC. | $726.4 mi | $7.0 mi | 1.0% | 1.0% | +11.1% | 17 |
| AMPHAmphastar Pharmaceuticals, Inc. | $719.9 mi | $98.1 mi | 13.6% | — | +15.5% | 14 |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | $719.0 mi | -$38.5 mi | -5.4% | -3.7% | +6.7% | 16 |
| KNSAKiniksa Pharmaceuticals International, p | $677.6 mi | $59.0 mi | 8.7% | 11.7% | — | 5 |
| RAREUltragenyx Pharmaceutical Inc. | $673.0 mi | -$575.0 mi | -85.4% | -657.1% | +19.9% | 10 |
| AXSMAXSOME THERAPEUTICS, INC. | $638.5 mi | -$183.2 mi | -28.7% | -252.1% | — | 4 |
| TGTXTG THERAPEUTICS, INC. | $616.3 mi | $447.2 mi | 72.6% | 102.8% | +426.7% | 10 |
| OPKOPKO Health, Inc. | $606.9 mi | -$225.7 mi | -37.2% | -17.1% | -15.8% | 17 |
| INSMINSMED INCORPORATED | $606.4 mi | -$1.28 bi | -210.5% | -249.3% | +29.8% | 16 |
| CPRXCATALYST PHARMACEUTICALS, INC. | $589.0 mi | $214.3 mi | 36.4% | 25.5% | +37.7% | 14 |
| HCMHutchMED (China) LIMITED | $548.5 mi | $456.9 mi | 83.3% | 45.7% | +19.2% | 12 |
| MIRMMirum Pharmaceuticals, Inc. | $521.3 mi | -$23.4 mi | -4.5% | -8.6% | — | 6 |
| BBIOBridgeBio Pharma, Inc. | $502.1 mi | -$732.9 mi | -146.0% | — | +127.4% | 7 |
| TVTXTRAVERE THERAPEUTICS, INC. | $490.7 mi | -$25.5 mi | -5.2% | -29.4% | +19.9% | 15 |
| ZLABZAI LAB LIMITED | $457.2 mi | -$175.5 mi | -38.4% | -22.6% | +56.3% | 8 |
| INVAINNOVIVA, INC. | $411.3 mi | $271.2 mi | 65.9% | 29.1% | +4.1% | 17 |
| ARDXARDELYX, INC. | $407.3 mi | -$61.6 mi | -15.1% | -36.2% | +121.9% | 13 |
| ARQTARCUTIS BIOTHERAPEUTICS, INC. | $372.1 mi | -$16.1 mi | -4.3% | -9.3% | — | 6 |
| MNKDMannKind Corporation | $349.0 mi | $5.9 mi | 1.7% | — | +39.9% | 16 |
| XERSXERIS BIOPHARMA HOLDINGS, INC. | $291.8 mi | $554,000 | 0.2% | — | +70.7% | 6 |
| AUPHAurinia Pharmaceuticals Inc. | $283.1 mi | $287.2 mi | 101.5% | 59.9% | +41.4% | 8 |
| HROWHarrow, Inc. | $272.3 mi | -$5.1 mi | -1.9% | -8.4% | +41.0% | 13 |
| LGNDLIGAND PHARMACEUTICALS INC | $268.1 mi | $124.5 mi | 46.4% | 13.5% | +10.4% | 17 |
| SDGRSchrodinger, Inc. | $255.9 mi | -$103.3 mi | -40.4% | -26.3% | +18.8% | 7 |
| AKBAAKEBIA THERAPEUTICS, INC. | $236.2 mi | -$5.3 mi | -2.3% | — | -4.3% | 12 |
| IDYAIDEAYA Biosciences, Inc. | $218.7 mi | -$113.7 mi | -52.0% | -10.9% | +62.1% | 7 |
| RYTMRHYTHM PHARMACEUTICALS, INC. | $189.8 mi | -$196.5 mi | -103.6% | -244.5% | — | 10 |
| SNDXSyndax Pharmaceuticals, Inc. | $172.4 mi | -$285.4 mi | -165.6% | -161.8% | +157.7% | 11 |
| CYTKCytokinetics, Incorporated | $88.0 mi | -$785.0 mi | -891.6% | — | +9.5% | 17 |
| NRIXNURIX THERAPEUTICS, INC. | $84.0 mi | -$264.5 mi | -314.9% | -49.6% | +36.3% | 7 |
| ABCLAbCellera Biologics Inc. | $75.1 mi | -$146.4 mi | -194.9% | -14.5% | -20.3% | 7 |
| VRDNViridian Therapeutics, Inc.\DE | $70.8 mi | -$342.6 mi | -483.6% | -49.2% | +132.2% | 13 |
| AGIOAgios Pharmaceuticals, Inc. | $54.0 mi | -$412.8 mi | -764.0% | -30.2% | — | 15 |
| OCULOcular Therapeutix, Inc. | $52.0 mi | -$265.9 mi | -511.9% | -54.9% | +24.4% | 13 |
| PTGXPROTAGONIST THERAPEUTICS, INC. | $46.0 mi | -$130.1 mi | -282.8% | -20.2% | +10.0% | 9 |
| WVEWAVE LIFE SCIENCES LTD. | $42.7 mi | -$204.4 mi | -478.3% | -56.2% | +16.3% | 11 |
| RCUSArcus Biosciences, Inc. | $33.0 mi | -$353.0 mi | -1069.7% | -63.3% | -15.8% | 9 |
| NAMSNewAmsterdam Pharma Company N.V. | $22.5 mi | -$203.8 mi | -905.7% | -28.3% | — | 4 |
| QUREuniQure N.V. | $16.1 mi | -$199.0 mi | -1236.0% | -207.1% | -15.6% | 12 |
| JANXJanux Therapeutics, Inc. | $10.0 mi | -$113.6 mi | -1136.2% | -11.5% | — | 6 |
| ROIVROIVANT SCIENCES LTD. | $8.3 mi | -$299.8 mi | -3629.2% | -6.5% | -19.1% | 6 |
| CRNXCrinetics Pharmaceuticals, Inc. | $7.7 mi | -$465.3 mi | -6046.2% | -40.2% | +155.3% | 10 |
| XENEXenon Pharmaceuticals Inc. | $7.5 mi | -$345.9 mi | -4612.1% | -51.8% | -25.3% | 13 |
| COGTCogent Biosciences, Inc. | — | -$328.9 mi | — | -73.7% | — | 4 |
| GERNGERON CORPORATION | — | -$83.5 mi | — | -33.0% | — | 15 |
| MLTXMOONLAKE IMMUNOTHERAPEUTICS | — | -$227.3 mi | — | -60.5% | — | 0 |
| PRAXPRAXIS PRECISION MEDICINES, INC. | $0 | -$303.3 mi | — | -45.8% | — | 4 |
| SMMTSummit Therapeutics Inc. | — | -$1.08 bi | — | -206.1% | — | 6 |
| SYRESpyre Therapeutics, Inc. | $0 | -$155.2 mi | — | -25.2% | — | 10 |
| VKTXVIKING THERAPEUTICS, INC. | $0 | -$359.6 mi | — | -47.3% | — | 12 |
| TAKTakeda Pharmaceutical Company Limited | JPY 4.58 tri | JPY 107.93 bi | 2.4% | 1.5% | +6.8% | 9 |
| RDYDR. REDDY’S LABORATORIES LIMITED | INR 325.54 bi | INR 56.54 bi | 17.4% | 18.4% | +13.3% | 10 |
| NVONOVO NORDISK A/S | DKK 309.06 bi | DKK 102.43 bi | 33.1% | — | +19.5% | 7 |
| SNYSanofi | EUR 43.63 bi | EUR 7.81 bi | 17.9% | 10.5% | +3.9% | 11 |
| GSKGSK plc | GBP 32.67 bi | GBP 5.72 bi | 17.5% | 38.0% | +6.0% | 11 |
| GRFSGrifols SA | EUR 7.21 bi | EUR 156.9 mi | 2.2% | 2.8% | +7.2% | 10 |
| GMABGenmab A/S | DKK 3.72 bi | DKK 963.0 mi | 25.9% | — | — | 6 |
| LKFTGALAPAGOS NV | EUR 1.11 bi | EUR 320.9 mi | 28.8% | — | +18.4% | 11 |
| EVOEvotec SE | EUR 797.0 mi | -EUR 196.1 mi | -24.6% | -18.9% | +12.3% | 6 |
| ASNDAscendis Pharma A/S | EUR 720.1 mi | -EUR 228.0 mi | -31.7% | — | +153.0% | 11 |
| PAHCPhibro Animal Health Corporation | $1.30 bi | $48.3 mi | 3.7% | 17.8% | +10.1% | 14 |
| EBSEMERGENT BIOSOLUTIONS INC. | $742.9 mi | $52.6 mi | 7.1% | 10.5% | -14.0% | 17 |
| ORGOORGANOGENESIS HOLDINGS INC. | $564.2 mi | $37.0 mi | 6.6% | 13.2% | +10.8% | 10 |
| NATRNATURES SUNSHINE PRODUCTS INC | $480.1 mi | $19.5 mi | 4.1% | — | +4.5% | 17 |
| SVASINOVAC BIOTECH LTD | $386.0 mi | -$198.8 mi | -51.5% | -3.1% | -5.4% | 17 |
| PHARPharming Group N.V. | $376.1 mi | $2.9 mi | 0.8% | — | +12.1% | 8 |
| EOLSEVOLUS, INC. | $297.2 mi | -$51.6 mi | -17.4% | — | +39.4% | 8 |
| IRWDIRONWOOD PHARMACEUTICALS, INC. | $296.2 mi | $24.0 mi | 8.1% | — | -5.3% | 17 |
| RIGLRIGEL PHARMACEUTICALS INC | $294.3 mi | $367.0 mi | 124.7% | 185.9% | +22.1% | 10 |
| ARVNARVINAS, INC. | $262.6 mi | -$80.8 mi | -30.8% | -16.2% | +58.9% | 9 |
| LFVNLifevantage Corp | $228.5 mi | $9.8 mi | 4.3% | 32.3% | -0.4% | 15 |
| PBYIPUMA BIOTECHNOLOGY, INC. | $228.4 mi | $31.1 mi | 13.6% | 28.0% | +0.3% | 9 |
| VNDAVANDA PHARMACEUTICALS INC. | $216.1 mi | -$220.5 mi | -102.0% | -50.9% | -2.7% | 17 |
| AMRNAMARIN CORP PLC\UK | $213.6 mi | -$38.8 mi | -18.2% | -8.2% | -19.0% | 13 |
| MRVIMaravai LifeSciences Holdings, Inc. | $185.7 mi | -$130.8 mi | -70.4% | -48.6% | -8.1% | 7 |
| KMDAKamada Ltd. | $180.5 mi | $20.2 mi | 11.2% | — | +6.3% | 11 |
| CYRXCryoport, Inc. | $176.2 mi | $78.3 mi | 44.4% | 17.3% | +17.5% | 16 |
| HRTXHERON THERAPEUTICS, INC. /DE/ | $154.9 mi | -$20.2 mi | -13.0% | — | +11.8% | 10 |
| LFCRLIFECORE BIOMEDICAL, INC. | $128.9 mi | -$38.7 mi | -30.0% | -612.1% | -4.2% | 16 |
| XNCRXencor, Inc | $125.6 mi | -$91.9 mi | -73.2% | -14.0% | +0.5% | 10 |
| GYREGyre Therapeutics, Inc. | $116.6 mi | $9.9 mi | 8.5% | 11.7% | +41.0% | 14 |
| SIGASIGA Technologies, Inc. | $94.6 mi | $23.3 mi | 24.6% | 11.2% | -5.4% | 10 |
| LABSTANDARD BIOTOOLS INC. | $85.3 mi | -$74.9 mi | -87.8% | -16.7% | -9.2% | 17 |
| ARCTARCTURUS THERAPEUTICS HOLDINGS INC. | $82.0 mi | -$65.8 mi | -80.2% | -28.9% | +53.8% | 8 |
| CTMXCytomX Therapeutics, Inc. | $76.2 mi | -$17.4 mi | -22.8% | -35.2% | +2.2% | 13 |
| PRTAPROTHENA CORPORATION PUBLIC LIMITED COMP | $9.7 mi | -$244.1 mi | -2520.6% | -63.6% | +62.6% | 14 |
| ADAGAdagene Inc. | $7.7 mi | -$17.6 mi | -229.6% | -41.0% | +61.4% | 8 |
| PTCHFPURETECH HEALTH PLC | $4.8 mi | $53.5 mi | 1108.3% | 12.2% | -13.2% | 7 |
| NBTXNanobiotix S.A. | EUR 32.6 mi | -EUR 24.0 mi | -73.5% | — | +67.0% | 8 |
| PRQRProQR Therapeutics N.V. | EUR 15.9 mi | -EUR 42.2 mi | -265.2% | -61.2% | — | 5 |
| IMMPImmutep Limited | AUD 10.3 mi | -AUD 61.4 mi | -594.6% | -36.9% | -8.9% | 10 |
| IVAInventiva S.A. | EUR 9.2 mi | -EUR 184.2 mi | -2002.7% | — | +5.6% | 7 |
| ACIUAC IMMUNE SA | CHF 3.6 mi | -CHF 70.4 mi | -1971.6% | — | -25.4% | 11 |
| UPCUniverse Pharmaceuticals INC | $17.86 bi | -$3.67 bi | -20.6% | -7.2% | +257.2% | 7 |
| CRMDCORMEDIX INC. | $311.7 mi | $163.1 mi | 52.3% | 66.6% | +319.7% | 13 |
| KROSKEROS THERAPEUTICS, INC. | $244.1 mi | $87.0 mi | 35.7% | 19.9% | — | 7 |
| ANABANAPTYSBIO, INC. | $234.6 mi | -$13.2 mi | -5.6% | -24.5% | +25.6% | 11 |
| STOKStoke Therapeutics, Inc. | $184.4 mi | -$6.9 mi | -3.7% | -2.4% | — | 4 |
| PHATPHATHOM PHARMACEUTICALS, INC. | $175.1 mi | -$221.2 mi | -126.3% | — | — | 4 |
| LQDALIQUIDIA CORPORATION | $158.3 mi | -$68.9 mi | -43.5% | -111.1% | +192.5% | 7 |
| MGNXMACROGENICS, INC. | $149.5 mi | -$74.6 mi | -49.9% | -86.9% | +7.3% | 15 |
| ELTPElite Pharmaceuticals, Inc. | $148.9 mi | $44.9 mi | 30.1% | 58.9% | +42.4% | 16 |
| KPTIKaryopharm Therapeutics Inc. | $146.1 mi | -$196.0 mi | -134.2% | — | +6.2% | 15 |
| URGNUroGen Pharma Ltd. | $109.8 mi | -$153.5 mi | -139.8% | — | +56.2% | 10 |
| TBPHTHERAVANCE BIOPHARMA, INC. | $107.5 mi | $105.9 mi | 98.5% | 44.8% | +8.4% | 14 |
| ZVRAZevra Therapeutics, Inc. | $106.5 mi | $83.2 mi | 78.2% | 85.7% | +51.6% | 11 |
| ZYMEZYMEWORKS INC. | $106.0 mi | -$81.1 mi | -76.6% | -26.7% | +22.2% | 6 |
| SPRYARS Pharmaceuticals, Inc. | $84.3 mi | -$171.3 mi | -203.3% | -92.3% | — | 5 |
| ADCTADC Therapeutics SA | $81.4 mi | -$142.6 mi | -175.3% | — | — | 4 |
| ETONEton Pharmaceuticals, Inc. | $80.0 mi | -$4.6 mi | -5.8% | -18.2% | +359.6% | 7 |
| BCYCBicycle Therapeutics plc | $72.6 mi | -$219.0 mi | -301.7% | -31.2% | +47.5% | 9 |
| ASMBASSEMBLY BIOSCIENCES, INC. | $72.3 mi | -$6.1 mi | -8.5% | -5.1% | -1.8% | 10 |
| RMTIROCKWELL MEDICAL, INC. | $69.3 mi | -$5.3 mi | -7.7% | -15.3% | +2.2% | 17 |
| KURAKURA ONCOLOGY, INC. | $67.5 mi | -$278.7 mi | -412.9% | -94.8% | — | 3 |
| AYTUAYTU BIOPHARMA, INC | $66.4 mi | -$13.6 mi | -20.4% | -58.1% | +19.2% | 13 |
| ENTAENANTA PHARMACEUTICALS INC | $65.3 mi | -$81.9 mi | -125.4% | -84.6% | -11.8% | 15 |
| NUVBNuvation Bio Inc. | $62.9 mi | -$204.6 mi | -325.3% | -53.2% | — | 3 |
| TNGXTango Therapeutics, Inc. | $62.4 mi | -$101.6 mi | -162.9% | -37.2% | +52.1% | 6 |
| FBIOFortress Biotech, Inc. | $61.2 mi | $6.8 mi | 11.1% | 18.8% | +6.6% | 13 |
| NKTRNEKTAR THERAPEUTICS | $55.2 mi | -$164.1 mi | -297.1% | -217.9% | -18.4% | 17 |
| INBPINTEGRATED BIOPHARMA INC | $54.4 mi | $808,000 | 1.5% | 4.1% | +0.6% | 15 |
| QTTBQ32 Bio Inc. | $53.7 mi | $29.8 mi | 55.5% | 125.1% | +81.9% | 8 |
| LXRXLexicon Pharmaceuticals, Inc. | $49.8 mi | -$50.3 mi | -101.1% | -39.7% | +16.3% | 17 |
| GOSSGossamer Bio, Inc. | $48.5 mi | -$170.4 mi | -351.5% | — | — | 4 |
| AQSTAquestive Therapeutics, Inc. | $44.5 mi | -$83.8 mi | -188.1% | — | -0.6% | 9 |
| CPIXCUMBERLAND PHARMACEUTICALS INC | $44.5 mi | -$2.8 mi | -6.4% | -11.9% | +4.4% | 17 |
| BFRIBiofrontera Inc. | $41.7 mi | -$10.5 mi | -25.3% | -141.3% | +17.2% | 6 |
| BGMBGM Group Ltd | $37.9 mi | -$19.9 mi | -52.6% | -9.2% | -5.4% | 8 |
| LIFDLFTD PARTNERS INC. | $36.9 mi | -$24.9 mi | -67.3% | -99.2% | +47.2% | 10 |
| SBFMSUNSHINE BIOPHARMA INC. | $36.3 mi | -$6.0 mi | -16.5% | -25.7% | +247.7% | 16 |
| ETSTEARTH SCIENCE TECH, INC. | $35.7 mi | $3.6 mi | 10.2% | 66.9% | +202.5% | 13 |
| VRCAVerrica Pharmaceuticals Inc. | $35.6 mi | -$17.9 mi | -50.3% | -240.4% | — | 5 |
| ZOMDFZomedica Corp. | $32.0 mi | -$81.9 mi | -255.6% | -52.6% | — | 6 |
| VSTMVerastem, Inc. | $30.9 mi | -$209.5 mi | -677.6% | -1480.2% | -19.0% | 7 |
| FHTXFoghorn Therapeutics Inc. | $30.9 mi | -$74.3 mi | -240.3% | — | +135.1% | 6 |
| PREPrenetics Global Limited | $30.6 mi | -$46.3 mi | -151.2% | -24.6% | — | 5 |
| CUECue Biopharma, Inc. | $27.5 mi | -$26.6 mi | -96.9% | -121.1% | +54.2% | 8 |
| CASIFCASI PHARMACEUTICALS, INC. | $20.7 mi | -$48.1 mi | -232.0% | — | +6.5% | 6 |
| SCYXSCYNEXIS, Inc. | $20.6 mi | -$8.6 mi | -41.8% | -16.5% | — | 13 |
| EVFMEVOFEM BIOSCIENCES, INC. | $20.2 mi | $391,000 | 1.9% | — | +114.4% | 7 |
| IRDOpus Genetics, Inc. | $14.2 mi | -$49.6 mi | -349.3% | -449.4% | — | 12 |
| ABUSArbutus Biopharma Corp | $14.1 mi | -$33.5 mi | -237.9% | -38.5% | +15.3% | 17 |
| CVSICV Sciences, Inc. | $13.8 mi | -$958,000 | -6.9% | -58.7% | -10.8% | 14 |
| TNXPTonix Pharmaceuticals Holding Corp. | $13.1 mi | -$124.0 mi | -946.2% | -64.5% | — | 3 |
| SPROSpero Therapeutics, Inc. | $12.6 mi | $8.6 mi | 68.1% | 16.3% | +117.6% | 10 |
| EMMAEMMAUS LIFE SCIENCES, INC. | $12.5 mi | -$7.5 mi | -60.2% | — | -11.7% | 15 |
| JAGXJaguar Health, Inc. | $11.5 mi | -$53.6 mi | -465.4% | — | +4.2% | 12 |
| CBIOCRESCENT BIOPHARMA, INC. | $10.8 mi | -$153.9 mi | -1419.6% | -164.2% | +1.3% | 10 |
| XOMAXOMA Royalty Corporation | $10.3 mi | $31.7 mi | 306.4% | 43.5% | -18.0% | 17 |
| ZBIOZenas BioPharma, Inc. | $10.0 mi | -$377.7 mi | -3777.4% | -136.2% | — | 3 |
| PGENPRECIGEN, INC. | $9.7 mi | -$250.6 mi | -2588.2% | -843.6% | -21.3% | 15 |
| ISCOINTERNATIONAL STEM CELL CORPORATION | $9.1 mi | -$418,000 | -4.6% | — | +5.0% | 16 |
| RDHLREDHILL BIOPHARMA LTD. | $8.0 mi | -$8.3 mi | -102.8% | — | +5.0% | 10 |
| ACRSAclaris Therapeutics, Inc. | $7.8 mi | -$64.9 mi | -829.6% | -50.2% | +3.8% | 9 |
| OVIDOvid Therapeutics Inc. | $7.3 mi | -$17.4 mi | -240.1% | -17.5% | -10.5% | 6 |
| WHWKWhitehawk Therapeutics, Inc. | $7.1 mi | -$20.6 mi | -288.3% | -21.8% | -12.6% | 8 |
| IMNMImmunome, Inc. | $6.9 mi | -$212.4 mi | -3060.0% | -52.1% | — | 3 |
| KYNBKYNTRA BIO, INC. | $6.4 mi | $183.5 mi | 2848.6% | — | -48.4% | 13 |
| KRROKorro Bio, Inc. | $6.4 mi | -$117.3 mi | -1834.5% | — | -29.6% | 7 |
| ABEOABEONA THERAPEUTICS INC. | $5.8 mi | $71.2 mi | 1223.1% | 70.0% | -10.3% | 14 |
| ENSCEnsysce Biosciences, Inc. | $5.1 mi | -$10.2 mi | -200.8% | -294.0% | +5.2% | 6 |
| PCYNPROCYON CORPORATION | $5.0 mi | -$341,140 | -6.8% | -13.9% | +3.5% | 14 |
| INMINMED PHARMACEUTICALS INC. | $4.9 mi | -$8.2 mi | -165.1% | -72.1% | — | 5 |
| PRPHProPhase Labs, Inc. | $4.3 mi | -$14.7 mi | -339.3% | -271.5% | -21.4% | 17 |
| CPHICHINA PHARMA HOLDINGS, INC. | $4.1 mi | -$3.2 mi | -76.9% | -20.9% | -17.5% | 16 |
| CRVOCERVOMED INC. | $4.0 mi | -$27.0 mi | -673.1% | -93.9% | — | 8 |
| SLGLSol-Gel Technologies Ltd. | $3.8 mi | -$6.1 mi | -161.2% | -23.7% | -15.2% | 9 |
| RADXRadiopharm Theranostics Limited | $3.6 mi | -$38.3 mi | -1055.3% | — | — | 3 |
| MRKRMARKER THERAPEUTICS, INC. | $3.5 mi | -$12.2 mi | -343.0% | -68.8% | +50.0% | 9 |
| TXMDTherapeuticsMD, Inc. | $3.0 mi | -$569,000 | -18.8% | -2.1% | -45.8% | 15 |
| XBIOXENETIC BIOSCIENCES, INC. | $3.0 mi | -$2.7 mi | -90.1% | -40.0% | +46.8% | 14 |
| TRAWTraws Pharma, Inc. | $2.8 mi | $9.2 mi | 328.7% | — | +64.6% | 15 |
| GOVXGEOVAX LABS, INC. | $2.5 mi | -$21.5 mi | -862.3% | -483.8% | +6.4% | 10 |
| CYCNCYCLERION THERAPEUTICS, INC. | $2.1 mi | -$3.5 mi | -170.1% | -39.3% | -2.0% | 7 |
| DNTHDianthus Therapeutics, Inc. | $2.0 mi | -$162.3 mi | -7973.3% | -38.4% | — | 7 |
| ORMPORAMED PHARMACEUTICALS INC. | $2.0 mi | $64.0 mi | 3212.1% | 37.0% | -5.9% | 9 |
| LPCNLIPOCINE INC. | $2.0 mi | -$9.6 mi | -487.1% | -54.3% | — | 12 |
| CLSDQClearside Biomedical, Inc. | $1.7 mi | -$34.4 mi | -2064.4% | — | -5.2% | 9 |
| ATXIAVENUE THERAPEUTICS, INC. | $1.4 mi | -$2.9 mi | -207.2% | -125.7% | — | 2 |
| NWBONORTHWEST BIOTHERAPEUTICS INC | $1.4 mi | -$60.2 mi | -4365.9% | — | +1.3% | 16 |
| CPMDCANNAPHARMARX, INC. | $1.4 mi | -$11.1 mi | -817.2% | — | — | 13 |
| SPRCSCISPARC LTD. | $1.3 mi | -$6.3 mi | -481.2% | -79.7% | — | 3 |
| IGCIGC PHARMA, INC. | $1.3 mi | -$7.1 mi | -560.3% | -104.3% | -20.8% | 15 |
| VTGNVistagen Therapeutics, Inc. | $1.3 mi | -$69.7 mi | -5491.3% | -131.6% | +3.1% | 13 |
| NRXPNRX Pharmaceuticals, Inc. | $1.2 mi | -$28.6 mi | -2336.5% | — | — | 3 |
| BLRXBioLineRx Ltd. | $1.2 mi | -$2.0 mi | -171.7% | -12.8% | — | 5 |
| SXTCChina SXT Pharmaceuticals, Inc. | $1.1 mi | -$6.2 mi | -545.2% | -27.5% | -24.9% | 10 |
| DAREDare Bioscience, Inc. | $1.0 mi | -$13.4 mi | -1300.7% | — | — | 9 |
| STTKShattuck Labs, Inc. | $1.0 mi | -$48.8 mi | -4880.9% | -60.3% | -36.8% | 7 |
| HYPDHYPERION DEFI, INC. | $813,455 | -$45.3 mi | -5570.6% | -324.1% | -16.5% | 5 |
| MCRBSeres Therapeutics, Inc. | $789,000 | $5.7 mi | 721.9% | 19.6% | -41.9% | 11 |
| LEXXLEXARIA BIOSCIENCE CORP. | $705,923 | -$11.9 mi | -1686.0% | -215.9% | +17.5% | 12 |
| PMHSPolomar Health Services, Inc. | $648,231 | -$10.7 mi | -1650.8% | -290.1% | — | 4 |
| BTAIBioXcel Therapeutics, Inc. | $642,000 | -$69.9 mi | -10887.4% | — | — | 4 |
| VCNXVaccinex, Inc. | $601,000 | -$18.6 mi | -3100.5% | — | +2.8% | 8 |
| VYNEVYNE THERAPEUTICS INC. | $570,000 | -$26.5 mi | -4646.1% | -66.3% | -51.4% | 10 |
| SLNSilence Therapeutics plc | $559,000 | -$88.6 mi | -15851.9% | -90.3% | — | 4 |
| SCNXScienture Holdings, Inc. | $431,609 | -$41.5 mi | -9618.0% | -55.6% | -52.1% | 13 |
| MNOVMEDICINOVA, INC. | $409,657 | -$12.0 mi | -2928.8% | -25.5% | — | 5 |
| CANFCan-Fite BioPharma Ltd. | $405,000 | -$9.8 mi | -2426.7% | -178.2% | -11.9% | 8 |
| IBIOiBio, Inc. | $400,000 | -$18.4 mi | -4594.2% | -101.5% | -24.6% | 15 |
| RNACCartesian Therapeutics, Inc. | $400,000 | -$130.3 mi | -32575.5% | — | -52.5% | 12 |
| PVCTPROVECTUS BIOPHARMACEUTICALS, INC. | $336,108 | -$5.4 mi | -1615.8% | — | — | 9 |
| ABVCABVC BioPharma, Inc. | $296,000 | -$7.9 mi | -2671.8% | -128.2% | -9.3% | 14 |
| CLNNCLENE INC. | $200,000 | -$26.2 mi | -13086.5% | — | -0.6% | 6 |
| LSTALISATA THERAPEUTICS, INC. | $170,000 | -$16.6 mi | -9756.5% | -74.7% | — | 11 |
| SERSerina Therapeutics, Inc. | $130,000 | -$19.2 mi | -14755.4% | -6351.7% | -18.5% | 9 |
| ATNMACTINIUM PHARMACEUTICALS, INC. | $90,000 | -$33.9 mi | -37652.2% | -167.0% | — | 6 |
| SILOSilo Pharma, Inc. | $72,102 | -$4.2 mi | -5863.5% | -74.6% | +12.0% | 6 |
| INOINOVIO PHARMACEUTICALS, INC. | $65,343 | -$84.9 mi | -130000.0% | -183.5% | -61.2% | 17 |
| CNTBConnect Biopharma Holdings Ltd | $64,000 | -$55.5 mi | -86687.5% | -82.7% | — | 3 |
| AVTXAvalo Therapeutics, Inc. | $59,000 | -$78.3 mi | -132642.4% | -72.4% | -61.2% | 11 |
| ALTAltimmune, Inc. | $41,000 | -$88.1 mi | -214861.0% | -50.6% | -65.3% | 12 |
| AXIMAXIM BIOTECHNOLOGIES, INC. | $39,518 | -$8.1 mi | -20395.0% | — | -27.4% | 13 |
| LYELLyell Immunopharma, Inc. | $36,000 | -$274.4 mi | -762355.6% | -87.0% | -65.9% | 7 |
| RFLRAFAEL HOLDINGS, INC. | $30,000 | -$30.5 mi | -101733.3% | -34.6% | -63.9% | 10 |
| TLPHTALPHERA, INC. | $28,000 | -$14.3 mi | -51035.7% | -114.2% | -65.1% | 15 |
| SKVISkinvisible, Inc. | $20,000 | -$1.1 mi | -5320.2% | — | -33.4% | 16 |
| BDPTBioAdaptives Inc. | $18,278 | -$1.6 mi | -8523.4% | — | +2.3% | 7 |
| PRFXPRF Technologies Ltd. | $17,000 | -$5.0 mi | -29541.2% | -96.9% | — | 3 |
| TCRTAlaunos Therapeutics, Inc. | $5,000 | -$4.2 mi | -83520.0% | -198.1% | — | 11 |
| OWPCONE WORLD PRODUCTS, INC. | $4,863 | -$3.9 mi | -80917.4% | — | — | 5 |
| ADTXAditxt, Inc. | $3,195 | -$43.1 mi | -1349028.2% | -1183.4% | — | 5 |
| ALXOALX ONCOLOGY HOLDINGS INC | — | -$101.7 mi | — | -145.7% | — | 5 |
| AMLXAmylyx Pharmaceuticals, Inc. | $0 | -$144.7 mi | — | -61.6% | — | 5 |
| ANIXANIXA BIOSCIENCES, INC. | — | -$10.9 mi | — | -62.2% | — | 13 |
| ANVSAnnovis Bio, Inc. | $0 | -$28.9 mi | — | -220.6% | — | 6 |
| APLMApollomics Inc. | $0 | -$53.9 mi | — | — | — | 5 |
| APVOAptevo Therapeutics Inc. | — | -$26.0 mi | — | -234.6% | — | 8 |
| ATOSATOSSA THERAPEUTICS, INC. | — | -$34.8 mi | — | -62.7% | — | 5 |
| BETRFBETTERLIFE PHARMA INC. | — | -$9.1 mi | — | -529.6% | — | 0 |
| BIVIBioVie Inc. | — | -$17.5 mi | — | -101.6% | — | 0 |
| BIXTBIOXYTRAN, INC. | — | -$2.1 mi | — | — | — | 8 |
| BNTCBENITEC BIOPHARMA INC. | — | -$37.9 mi | — | -52.5% | — | 6 |
| BPTHBio-Path Holdings, Inc. | — | -$9.9 mi | — | -3325.7% | — | 8 |
| BQSTBIOQUEST CORP. | — | -$821,022 | — | — | — | 2 |
| BYSIBeyondSpring Inc. | $0 | -$1.0 mi | — | — | — | 12 |
| CAPRCAPRICOR THERAPEUTICS, INC. | $0 | -$105.0 mi | — | -46.6% | — | 15 |
| CATXPERSPECTIVE THERAPEUTICS, INC. | — | -$103.1 mi | — | -41.4% | — | 14 |
| CNBXCNBX PHARMACEUTICALS INC. | $0 | -$313,976 | — | — | — | 11 |
| COCPCOCRYSTAL PHARMA, INC. | — | -$8.8 mi | — | -111.4% | — | 3 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | — | -$78.5 mi | — | -54.2% | — | 8 |
| CTXRCITIUS PHARMACEUTICALS, INC. | — | -$39.7 mi | — | -57.8% | — | 9 |
| CYDYCYTODYN INC. | — | $3.7 mi | — | — | — | 3 |
| DCOYDecoy Therapeutics Inc. | — | -$12.5 mi | — | -338.3% | — | 8 |
| DMRADAMORA THERAPEUTICS, INC. | — | -$209.8 mi | — | -163.8% | — | 0 |
| EDSAEdesa Biotech, Inc. | — | -$7.2 mi | — | -99.6% | — | 9 |
| ELDNELEDON PHARMACEUTICALS, INC. | — | -$45.6 mi | — | -63.6% | — | 5 |
| ELVNEnliven Therapeutics, Inc. | — | -$103.7 mi | — | -27.0% | — | 0 |
| ENVBEnveric Biosciences, Inc. | — | -$8.8 mi | — | -304.0% | — | 5 |
| EQEQUILLIUM, INC. | — | -$22.4 mi | — | -94.0% | — | 3 |
| ERNAErnexa Therapeutics Inc. | — | -$14.1 mi | — | -686.7% | — | 14 |
| FBRXForte Biosciences, Inc. | — | -$69.4 mi | — | -122.3% | — | 4 |
| FLNAFilana Therapeutics, Inc. | — | -$91.0 mi | — | -82.7% | — | 5 |
| FULCFULCRUM THERAPEUTICS, INC. | $0 | -$74.9 mi | — | -25.3% | — | 6 |
| GCANTHE GREATER CANNABIS COMPANY, INC. | — | -$331,612 | — | — | — | 5 |
| GLMDGALMED PHARMACEUTICALS LTD. | — | -$10.3 mi | — | -64.2% | — | 7 |
| GNPXGenprex, Inc. | — | -$16.2 mi | — | -338.7% | — | 8 |
| GTBPGT BIOPHARMA, INC. | — | -$28.4 mi | — | -1377.4% | — | 10 |
| HEPAHEPION PHARMACEUTICALS, INC. | — | -$8.3 mi | — | -2058.6% | — | 4 |
| HSTCHST Global, Inc. | $0 | -$146,210 | — | — | — | 7 |
| HURATuHURA Biosciences, Inc./NV | $0 | -$30.1 mi | — | -169.2% | — | 5 |
| IMNNImunon, Inc. | — | -$14.5 mi | — | -256.4% | — | 6 |
| INTIInhibitor Therapeutics, Inc. | — | -$3.3 mi | — | -952.3% | — | 9 |
| ITRMFIterum Therapeutics plc | — | -$24.8 mi | — | — | — | 6 |
| KALAKALA BIO, Inc. | $0 | -$27.0 mi | — | -279.2% | — | 10 |
| KPRXKIORA PHARMACEUTICALS, INC. | $0 | -$10.8 mi | — | -51.7% | — | 10 |
| KTTAPASITHEA THERAPEUTICS CORP. | — | -$20.4 mi | — | -58.4% | — | 2 |
| LITSLite Strategy, Inc. | $0 | -$15.9 mi | — | -63.8% | — | 9 |
| LNAILunai Bioworks Inc. | — | -$178.0 mi | — | -321.8% | — | 4 |
| LRMRLARIMAR THERAPEUTICS, INC. | — | -$165.7 mi | — | -132.6% | — | 8 |
| MBIOMUSTANG BIO, INC. | — | -$1.9 mi | — | -67.9% | — | 0 |
| MBRXMoleculin Biotech, Inc. | $0 | -$33.6 mi | — | -256.0% | — | 10 |
| MNPRMonopar Therapeutics | $0 | -$13.7 mi | — | -14.2% | — | 6 |
| MTNBMatinas BioPharma Holdings, Inc. | — | -$10.3 mi | — | -166.6% | — | 10 |
| NERVMinerva Neurosciences, Inc. | — | -$293.4 mi | — | — | — | 8 |
| NGNENeurogene Inc. | $0 | -$90.4 mi | — | -31.4% | — | 4 |
| NIKANIKA PHARMACEUTICALS, INC. | — | -$76,398 | — | — | — | 4 |
| NKTXNkarta, Inc. | $0 | -$104.1 mi | — | -28.9% | — | 3 |
| NMADLIXTE BIOTECHNOLOGY HOLDINGS, INC. | — | -$6.1 mi | — | -115.9% | — | 5 |
| NNVCNANOVIRICIDES, INC. | $0 | -$9.5 mi | — | -99.7% | — | 3 |
| OGENOragenics, Inc. | — | -$9.8 mi | — | -243.9% | — | 11 |
| OMEROMEROS CORPORATION | — | -$3.4 mi | — | — | — | 12 |
| ORKAOruka Therapeutics, Inc. | — | -$105.4 mi | — | -22.3% | — | 10 |
| OTLCOncotelic Therapeutics, Inc. | — | $249.3 mi | — | 184.0% | — | 4 |
| PCSAProcessa Pharmaceuticals, Inc. | — | -$13.6 mi | — | -373.0% | — | 7 |
| PHIOPhio Pharmaceuticals Corp | — | -$8.7 mi | — | -69.9% | — | 8 |
| PKTXPROTOKINETIX, INCORPORATED | — | -$364,188 | — | -93.6% | — | 5 |
| PLRXPLIANT THERAPEUTICS, INC. | $0 | -$149.3 mi | — | -61.5% | — | 7 |
| PPBTPURPLE BIOTECH LTD. | — | -$26.4 mi | — | -124.0% | — | 4 |
| PTIXProtagenic Therapeutics, Inc.\new | $0 | -$5.5 mi | — | -236.1% | — | 8 |
| PTNPALATIN TECHNOLOGIES, INC. | $0 | -$17.3 mi | — | — | — | 14 |
| PULMPULMATRIX, INC. | — | -$5.2 mi | — | -80.9% | — | 12 |
| PVLAPalvella Therapeutics, Inc. | — | -$41.7 mi | — | -92.1% | — | 11 |
| QNRXQuoin Pharmaceuticals Ltd. | — | -$15.8 mi | — | -141.6% | — | 3 |
| QNTMQuantum BioPharma Ltd. | — | — | — | — | — | 1 |
| RCKTROCKET PHARMACEUTICALS, INC. | $0 | -$223.1 mi | — | -60.3% | — | 10 |
| RNTXREIN THERAPEUTICS, INC. | $0 | -$49.9 mi | — | -139.9% | — | 11 |
| SDEVStablecoin Development Corporation | — | -$630.8 mi | — | — | — | 16 |
| SLSSELLAS Life Sciences Group, Inc. | — | -$26.9 mi | — | -66.9% | — | 9 |
| SNGXSOLIGENIX, INC. | — | -$11.1 mi | — | -235.5% | — | 15 |
| SPRBSpruce Biosciences, Inc. | $0 | -$39.0 mi | — | -109.2% | — | 4 |
| SVRASavara Inc. | — | -$118.8 mi | — | -63.5% | — | 9 |
| SYBXSYNLOGIC, INC. | $0 | -$1.0 mi | — | -8.2% | — | 10 |
| TENXTENAX THERAPEUTICS, INC. | $0 | -$52.6 mi | — | -55.6% | — | 8 |
| TLSATiziana Life Sciences Ltd | — | -$11.9 mi | — | — | — | 0 |
| TPSTTempest Therapeutics, Inc. | — | -$26.3 mi | — | -203.6% | — | 5 |
| TVRDTVARDI THERAPEUTICS, INC. | — | -$18.2 mi | — | — | — | 13 |
| VBIOValion Bio, Inc. | — | -$8.9 mi | — | -91.8% | — | 4 |
| VERUVERU INC. | — | -$22.7 mi | — | -89.7% | — | 16 |
| VTVTvTv Therapeutics Inc. | $0 | -$27.0 mi | — | -70.4% | — | 13 |
| XBITXBIOTECH INC. | — | -$45.5 mi | — | -28.2% | — | 6 |
| XCUREXICURE, INC. | $0 | -$4.9 mi | — | -92.5% | — | 10 |
| ZNTLZentalis Pharmaceuticals, Inc. | $0 | -$137.1 mi | — | -49.5% | — | 4 |
| AAPGASCENTAGE PHARMA GROUP INTERNATIONAL | CNY 980.6 mi | -CNY 405.4 mi | -41.3% | -249.8% | — | 3 |
| INCRINTERCURE LTD. | ILS 238.8 mi | -ILS 67.8 mi | -28.4% | -15.9% | +93.0% | 6 |
| ZYBTZhengye Biotechnology Holding Limited | CNY 116.4 mi | -CNY 69.8 mi | -60.0% | -26.1% | — | 4 |
| HYFTMindWalk Holdings Corp. | CAD 24.5 mi | -CAD 30.2 mi | -123.3% | — | +11.8% | 6 |
| MCUJFMEDICURE INC. | CAD 21.9 mi | -CAD 1.0 mi | -4.7% | — | +1.7% | 10 |
| XTXXFADASTRA HOLDINGS LTD. | CAD 13.3 mi | -CAD 4.3 mi | -32.2% | — | — | 3 |
| IMRNIMMURON LIMITED | AUD 7.3 mi | -AUD 5.2 mi | -71.6% | — | +23.7% | 10 |
| RLFTYRELIEF THERAPEUTICS HOLDING SA | CHF 6.3 mi | -CHF 98.2 mi | -1551.5% | — | — | 3 |
| AVCRFAVRICORE HEALTH INC. | CAD 4.7 mi | -CAD 668,977 | -14.4% | — | — | 9 |
| ADXNAddex Therapeutics Ltd | CHF 404,102 | CHF 7.1 mi | 1746.0% | — | -31.9% | 7 |
| KZIAKazia Therapeutics Limited. | AUD 42,000 | -AUD 20.7 mi | -49290.5% | — | — | 8 |
| IFRXInflaRx N.V. | EUR 29,331 | -EUR 45.6 mi | -155582.1% | -624.6% | — | 3 |
| ATHEALTERITY THERAPEUTICS LIMITED | — | -AUD 12.1 mi | — | — | — | 3 |
| BDRXBiodexa Pharmaceuticals PLC | — | -GBP 6.4 mi | — | — | — | 9 |
| CYTOFAltamira Therapeutics Ltd. | — | -CHF 8.5 mi | — | -118.8% | — | 3 |
| NBPNovaBridge Biosciences | — | -CNY 46.3 mi | — | -21.4% | — | 7 |
| VREOFVIREO GROWTH INC. | $268.8 mi | -$68.1 mi | -25.3% | -37.5% | +40.4% | 6 |
| DERMJourney Medical Corp | $61.2 mi | -$11.4 mi | -18.7% | -44.0% | +6.6% | 6 |
| SEPNSepterna, Inc. | $46.0 mi | -$48.9 mi | -106.4% | -12.2% | — | 3 |
| BHSTBIOHARVEST SCIENCES INC. | $34.5 mi | -$11.1 mi | -32.3% | -83.2% | — | 3 |
| CELUCelularity Inc. | $26.6 mi | -$91.7 mi | -345.4% | — | +13.2% | 6 |
| TRDAENTRADA THERAPEUTICS, INC. | $25.4 mi | -$143.8 mi | -565.5% | -39.1% | — | 3 |
| COYACoya Therapeutics, Inc. | $7.9 mi | -$21.2 mi | -267.1% | -51.4% | — | 4 |
| BOLTBolt Biotherapeutics, Inc. | $7.7 mi | -$33.4 mi | -433.7% | -79.7% | +101.6% | 6 |
| CAMPCAMP4 Therapeutics Corporation | $3.5 mi | -$80.4 mi | -2298.5% | -145.1% | — | 3 |
| UPBUPSTREAM BIO, INC. | $2.9 mi | -$143.4 mi | -5026.0% | -35.4% | — | 3 |
| BIOEBIO ESSENCE CORP. | $1.9 mi | $896,197 | 47.2% | — | +14.6% | 6 |
| RANIRani Therapeutics Holdings, Inc. | $1.6 mi | -$29.7 mi | -1817.1% | -169.6% | +28.7% | 6 |
| LGVNLongeveron Inc. | $1.2 mi | -$22.7 mi | -1893.6% | -164.7% | -26.6% | 6 |
| BSPKBESPOKE EXTRACTS, INC. | $1.1 mi | -$1.0 mi | -92.8% | — | +78.2% | 6 |
| SXTP60 DEGREES PHARMACEUTICALS, INC. | $1.0 mi | -$7.4 mi | -732.5% | -196.4% | — | 4 |
| ONCOOnconetix, Inc. | $815,371 | -$14.0 mi | -1721.0% | -164.3% | — | 3 |
| ELABPMGC HOLDINGS INC. | $590,084 | -$7.7 mi | -1313.0% | -106.9% | — | 3 |
| LIPOLipella Pharmaceuticals Inc. | $536,357 | -$5.0 mi | -935.2% | -198.1% | — | 4 |
| HINDVYOME HOLDINGS, INC. | $319,714 | -$10.3 mi | -3209.7% | — | -51.0% | 12 |
| RGBPREGEN BIOPHARMA, INC. | $236,561 | -$1.3 mi | -538.8% | — | +16.5% | 12 |
| BFRGBULLFROG AI HOLDINGS, INC. | $116,670 | -$6.5 mi | -5569.6% | -183.0% | — | 3 |
| HCWBHCW Biologics Inc. | $54,232 | -$8.0 mi | -14677.1% | — | -57.9% | 6 |
| GNLXGENELUX CORPORATION | $8,000 | -$32.1 mi | -401812.5% | -170.0% | — | 4 |
| KAYSKAYA HOLDINGS, INC. | $7,134 | -$2.1 mi | -29168.2% | — | -62.9% | 11 |
| AZTRAZITRA, INC. | $0 | -$11.0 mi | — | -230.7% | — | 4 |
| BRNSBARINTHUS BIOTHERAPEUTICS PLC | $0 | -$66.4 mi | — | -65.0% | — | 6 |
| CTORCITIUS ONCOLOGY, INC. | — | -$24.8 mi | — | -54.4% | — | 0 |
| DSGNDesign Therapeutics, Inc. | $0 | -$69.8 mi | — | -30.7% | — | 3 |
| ELTXElicio Therapeutics, Inc. | — | -$39.6 mi | — | — | — | 3 |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | $0 | -$38.6 mi | — | -66.8% | — | 3 |
| GANXGAIN THERAPEUTICS, INC | — | -$20.2 mi | — | -155.7% | — | 4 |
| IMRXImmuneering Corporation | — | -$56.0 mi | — | -43.1% | — | 4 |
| MAIAMAIA BIOTECHNOLOGY, INC. | — | -$22.4 mi | — | -745.2% | — | 3 |
| MSLESatellos Bioscience Inc. | — | -$24.9 mi | — | — | — | 0 |
| NXTSNexentis Technologies Inc. | — | -$4.0 mi | — | -38.6% | — | 7 |
| PTPIPetros Pharmaceuticals, Inc. | — | $1.9 mi | — | — | — | 5 |
| RGPXREGENEREX PHARMA, INC | — | -$2.5 mi | — | — | — | 2 |
| OGIORGANIGRAM HOLDINGS INC. | CAD 159.8 mi | -CAD 45.4 mi | -28.4% | — | +14.7% | 6 |
| PYRGFPYROGENESIS CANADA INC. | CAD 19.0 mi | -CAD 32.2 mi | -169.2% | — | — | 4 |
Publicidad
AdSense · Leaderboard 728×90 · responsive